These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. In vitro activity and post-antibiotic effects of colistin in combination with other antimicrobials against colistin-resistant KPC-producing Klebsiella pneumoniae bloodstream isolates. Gaibani P, Lombardo D, Lewis RE, Mercuri M, Bonora S, Landini MP, Ambretti S. J Antimicrob Chemother; 2014 Jul; 69(7):1856-65. PubMed ID: 24648503 [Abstract] [Full Text] [Related]
5. Outbreak of KPC-3-producing, and colistin-resistant, Klebsiella pneumoniae infections in two Sicilian hospitals. Mezzatesta ML, Gona F, Caio C, Petrolito V, Sciortino D, Sciacca A, Santangelo C, Stefani S. Clin Microbiol Infect; 2011 Sep; 17(9):1444-7. PubMed ID: 21668577 [Abstract] [Full Text] [Related]
6. Characterization of porin expression in Klebsiella pneumoniae Carbapenemase (KPC)-producing K. pneumoniae identifies isolates most susceptible to the combination of colistin and carbapenems. Hong JH, Clancy CJ, Cheng S, Shields RK, Chen L, Doi Y, Zhao Y, Perlin DS, Kreiswirth BN, Nguyen MH. Antimicrob Agents Chemother; 2013 May; 57(5):2147-53. PubMed ID: 23459476 [Abstract] [Full Text] [Related]
7. Synergistic activity of colistin plus rifampin against colistin-resistant KPC-producing Klebsiella pneumoniae. Tascini C, Tagliaferri E, Giani T, Leonildi A, Flammini S, Casini B, Lewis R, Ferranti S, Rossolini GM, Menichetti F. Antimicrob Agents Chemother; 2013 Aug; 57(8):3990-3. PubMed ID: 23752510 [Abstract] [Full Text] [Related]
9. Activity of Ceftazidime-Avibactam Alone and in Combination with Ertapenem, Fosfomycin, and Tigecycline Against Carbapenemase-Producing Klebsiella pneumoniae. Ojdana D, Gutowska A, Sacha P, Majewski P, Wieczorek P, Tryniszewska E. Microb Drug Resist; 2019 Nov; 25(9):1357-1364. PubMed ID: 31295055 [Abstract] [Full Text] [Related]
11. Evaluation of ceftazidime/avibactam alone and in combination with amikacin, colistin and tigecycline against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae by in vitro time-kill experiment. Wang F, Zhou Q, Yang X, Bai Y, Cui J. PLoS One; 2021 Nov; 16(10):e0258426. PubMed ID: 34648556 [Abstract] [Full Text] [Related]
12. Synergistic antibacterial effects of colistin in combination with aminoglycoside, carbapenems, cephalosporins, fluoroquinolones, tetracyclines, fosfomycin, and piperacillin on multidrug resistant Klebsiella pneumoniae isolates. Ontong JC, Ozioma NF, Voravuthikunchai SP, Chusri S. PLoS One; 2021 Nov; 16(1):e0244673. PubMed ID: 33406110 [Abstract] [Full Text] [Related]
13. Time-kill synergy tests of tigecycline combined with imipenem, amikacin, and ciprofloxacin against clinical isolates of multidrug-resistant Klebsiella pneumoniae and Escherichia coli. Yim H, Woo H, Song W, Park MJ, Kim HS, Lee KM, Hur J, Park MS. Ann Clin Lab Sci; 2011 Nov; 41(1):39-43. PubMed ID: 21325253 [Abstract] [Full Text] [Related]
20. Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay. Pournaras S, Vrioni G, Neou E, Dendrinos J, Dimitroulia E, Poulou A, Tsakris A. Int J Antimicrob Agents; 2011 Mar; 37(3):244-7. PubMed ID: 21236643 [Abstract] [Full Text] [Related] Page: [Next] [New Search]